Dormehl I C, Hugo N, Rossouw D, White A, Feinendegen L E
Institute for Life Sciences, University of Pretoria, South Africa.
Nucl Med Biol. 1995 Oct;22(7):837-47. doi: 10.1016/0969-8051(95)00015-p.
The purpose of this study was to compare by planar myocardial scintigraphy the kinetics of iodine-123-15-(iodophenyl)pentadecanoic acid (123I-pPPA and 123I-oPPA), and of iodine-123-(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid (BMIPP), firstly in normal baboons, and subsequently after blocking fatty acid oxidation by a carnitine palmitoyl transferase I(CPT1) inhibitor. The induced changes in myocardial metabolism were reflected in the dynamic behaviour of the three tracers. pPPA and oPPA to a large extent, provided information on beta-oxidation changes in the myocardium: beta-oxidation participation changed from 47% and 50%, respectively to 17% and 23% after inhibition. BMIPP provided better images and reflected largely on changed tracer incorporation into the neutral lipid pools. The beta-oxidation contributed only about 10% towards the metabolic pathway of BMIPP. The information obtained in this study could help determine the tracer of choice for SPECT, whereby myocardial viability could optimally be revealed.
本研究的目的是通过平面心肌闪烁显像术,首先在正常狒狒中,然后在使用肉碱棕榈酰转移酶I(CPT1)抑制剂阻断脂肪酸氧化后,比较碘-123-15-(碘苯基)十五烷酸(123I-pPPA和123I-oPPA)以及碘-123-(对碘苯基)-3-R,S-甲基十五烷酸(BMIPP)的动力学。心肌代谢的诱导变化反映在这三种示踪剂的动态行为中。pPPA和oPPA在很大程度上提供了有关心肌β氧化变化的信息:抑制后,β氧化参与率分别从47%和50%变为17%和23%。BMIPP提供了更好的图像,并在很大程度上反映了示踪剂掺入中性脂质池的变化。β氧化仅占BMIPP代谢途径的约10%。本研究获得的信息有助于确定单光子发射计算机断层显像(SPECT)的首选示踪剂,从而能够最佳地揭示心肌活力。